Links to Independent Reviews All Reviews
Apr 2015
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis of the PROSE trial
Aug 2013
ASCO Lung Cancer Highlights, Part 6: Predicting Benefit of Chemotherapy vs. EGFR inhibitor Therapy in Second Line by Dr. David Gerber
Aug 2013
NSCLC: Highlights From Chicago CME by Dr. Jared Weiss
Aug 2013
Lung cancer Update, Issue 2, 2013, featuring interview with Dr. Rogerio C. Lilenbaum